logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2020 – First-line therapy for RAS-BRAF wild-type metastatic colorectal cancer: focus on elderly

A fluoropyrimidine-based monotherapy in combination with an anti-EGFR is promising in elderly patients with unresectable disease.